高強度聚焦超音波 (HIFU) 市場機會、成長動力、產業趨勢分析及 2025-2034 年預測

2024 年全球高強度聚焦超音波市場規模達到 6.84 億美元，預計 2025 年至 2034 年期間的複合年成長率為 10.4%。隨著越來越多的醫療保健提供者和患者認知到 HIFU 技術在無需侵入性手術的情況下治療各種疾病的有效性，對 HIFU 技術的需求正在迅速成長。作為一種非侵入性療法，HIFU 已獲得 FDA 批准，可用於治療多種慢性疾病，包括腫瘤和特發性震顫。該技術利用聚焦超音波能量精確瞄準受影響的組織，最大限度地減少對周圍區域的損害。與傳統外科手術不同，HIFU 的恢復時間更快、疼痛減輕、治療後併發症更少，因此成為患者和醫療保健專業人員的首選。

影像技術和即時監控的進步進一步提高了HIFU治療的療效和安全性，推動了其在各個醫療領域的應用。人們對非侵入性治療方案的認知不斷提高，以及癌症、子宮肌瘤和神經系統疾病等疾病的盛行率不斷上升，繼續推動市場擴張。此外，向門診護理和微創治療的轉變正在重塑醫療保健行業，進一步將 HIFU 定位為現代醫學的遊戲規則改變者。隨著對經濟高效、低風險治療方案的需求激增，研發方面的投資正在推動更先進的 HIFU 設備的推出。市場參與者正在積極與醫療機構合作，以加速產品創新並擴大其全球影響力，確保 HIFU 技術在已開發經濟體和新興經濟體中廣泛應用。

市場按應用細分，主要治療領域包括皮膚科、子宮肌瘤、攝護腺癌、乳癌、青光眼、背痛和特發性震顫。 2024 年，皮膚病學將成為領先的細分市場，由於非侵入性美容手術的日益普及，皮膚病學將產生可觀的收入。由於 HIFU 能夠刺激膠原蛋白的產生並增強皮膚彈性，使其成為傳統美容手術的熱門替代品，因此面部拉皮、減少皺紋和緊緻皮膚等治療方法越來越受到人們的歡迎。由於沒有停機時間且效果持久，HIFU 在美容和保健領域繼續受到關注，進一步推動市場成長。

按最終用戶分類，醫院在 2024 年佔據 42.8% 的市場佔有率，在 HIFU 領域佔據主導地位。作為綜合醫療保健的主要提供者，醫院正在將 HIFU 整合到各種疾病的治療方案中。 FDA 和 CE 等機構的監管批准加強了醫院的採用，而對醫療保健基礎設施的投資不斷增加也繼續加強了這一領域。 HIFU 能夠滿足包括兒童和成人在內的不同患者群體的需求，這進一步推動了其在醫院環境中的應用。

美國高強度聚焦超音波 (HIFU) 市場在 2023 年創造了 2.239 億美元的產值，預計到 2034 年將達到 6.045 億美元。該國先進的醫療保健體系，加上前列腺癌的高發病率，正在推動 HIFU 的廣泛應用。強力的監管框架、不斷增加的醫療創新投資以及對非侵入性治療方案的認知不斷提高，都促進了市場擴張。隨著技術進步不斷提高 HIFU 的有效性和可近性，美國將繼續在全球 HIFU 領域發揮關鍵作用。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 慢性病發生率上升
    • 增加監管批准和報銷政策
    • 非侵入性療法日益受到青睞
    • 擴大在非癌症疾病的應用
  • 產業陷阱與挑戰
    • 設備和手術成本高昂
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 子宮肌瘤
• 攝護腺癌
• 特發性震顫
• 皮膚科
• 乳癌
• 青光眼
• 背痛
• 其他應用

第6章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 影像中心
• 其他最終用途

第7章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國

第8章：公司簡介

• ALPINION MEDICAL SYSTEMS
• Arrayus Technologies
• Chongqing Haifu Medical Technology
• Focal One
• FUSMobile
• Insightec
• Lynton Lasers
• Profound Medical
• Sonablate
• Theraclion
• ULTRAISER
• Verasonics

The Global High Intensity Focused Ultrasound Market reached USD 684 million in 2024 and is projected to grow at a CAGR of 10.4% between 2025 and 2034. The demand for HIFU technology is rising rapidly as more healthcare providers and patients recognize its effectiveness in treating various medical conditions without the need for invasive surgery. As a non-invasive therapy, HIFU has gained FDA approval for treating several chronic conditions, including tumors and essential tremors. The technology utilizes focused ultrasound energy to target affected tissues with precision, minimizing damage to surrounding areas. Unlike traditional surgical procedures, HIFU offers faster recovery times, reduced pain, and fewer post-treatment complications, making it a preferred choice for patients and healthcare professionals alike.

Advancements in imaging technology and real-time monitoring have further enhanced the efficacy and safety of HIFU treatments, driving its adoption across diverse medical fields. Increasing awareness of non-invasive therapeutic solutions and the rising prevalence of conditions such as cancer, fibroids, and neurological disorders continue to fuel market expansion. Additionally, the shift toward outpatient care and minimally invasive treatments is reshaping the healthcare industry, further positioning HIFU as a game-changer in modern medicine. As demand for cost-effective, low-risk treatment alternatives surges, investments in research and development are leading to the introduction of more sophisticated HIFU devices. Market players are actively collaborating with healthcare institutions to accelerate product innovation and expand their global footprint, ensuring widespread accessibility of HIFU technology in both developed and emerging economies.

The market is segmented by application, with key treatment areas including dermatology, uterine fibroids, prostate cancer, breast cancer, glaucoma, back pain, and essential tremors. In 2024, dermatology emerged as the leading segment, generating substantial revenue due to the rising popularity of non-invasive aesthetic procedures. Treatments such as facelifts, wrinkle reduction, and skin tightening have witnessed increased adoption, as HIFU's ability to stimulate collagen production and enhance skin elasticity makes it a sought-after alternative to traditional cosmetic procedures. With no downtime and long-lasting results, HIFU continues to gain traction in the beauty and wellness sector, further propelling market growth.

By end-user, hospitals accounted for a 42.8% market share in 2024, dominating the HIFU landscape. As key providers of comprehensive medical care, hospitals are integrating HIFU into treatment protocols for a wide range of conditions. Regulatory approvals from bodies like the FDA and CE have reinforced hospital adoption while increasing investments in healthcare infrastructure continue to strengthen this segment. The ability of HIFU to cater to diverse patient demographics, including children and adults, is further driving its use in hospital settings.

The U.S. High Intensity Focused Ultrasound (HIFU) Market generated USD 223.9 million in 2023 and is expected to reach USD 604.5 million by 2034. The country's advanced healthcare system, coupled with a high incidence of prostate cancer, is driving the widespread adoption of HIFU. The presence of a strong regulatory framework, increasing investment in healthcare innovation, and growing awareness of non-invasive treatment options are contributing to market expansion. As technological advancements continue to enhance the effectiveness and accessibility of HIFU, the U.S. is poised to remain a key player in the global HIFU landscape.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic diseases
    • 3.2.1.2 Increasing regulatory approvals and reimbursement policies
    • 3.2.1.3 Increasing preference for non-invasive therapies
    • 3.2.1.4 Expanding applications in non-cancer diseases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of equipment and procedures
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Uterine fibroids
• 5.3 Prostate cancer
• 5.4 Essential tremor
• 5.5 Dermatology
• 5.6 Breast cancer
• 5.7 Glaucoma
• 5.8 Backpain
• 5.9 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Imaging centers
• 6.4 Other End Use

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 ALPINION MEDICAL SYSTEMS
• 8.2 Arrayus Technologies
• 8.3 Chongqing Haifu Medical Technology
• 8.4 Focal One
• 8.5 FUSMobile
• 8.6 Insightec
• 8.7 Lynton Lasers
• 8.8 Profound Medical
• 8.9 Sonablate
• 8.10 Theraclion
• 8.11 ULTRAISER
• 8.12 Verasonics